Literature DB >> 19077686

Dopamine and angiotensin as renal counterregulatory systems controlling sodium balance.

John J Gildea1.   

Abstract

PURPOSE OF REVIEW: To review the recent evidence demonstrating how the renal dopaminergic and angiotensin systems control renal electrolyte balance through various receptor-mediated pathways with counterregulatory interactions. RECENT
FINDINGS: Stimulation of the renal rennin-angiotensin system results in increased sodium reabsorption, whereas the opposite is true for stimulation of the renal dopaminergic system. An underactive renal dopaminergic system has been associated with increased sodium reabsorption and hypertension. Recent findings indicate novel cell surface receptor-mediated mechanisms by which these two renal endocrine systems directly counterregulate each other. Each of the dopamine receptors (D1R through D5R) have been implicated in dopamine-mediated natriuresis, in addition to counterregulating the angiotensin type 1 R. Dopamine D1-like (D1R and D5R) stimulation has also been found to induce an AT2 receptor- dependent natriuresis. Recently, it has also been discovered that reactive oxygen species can play a role in inactivating the D1 receptor and activating the angiotensin type 1 R.
SUMMARY: Current therapeutic interventions for hypertension predominantly involve correction of an overactive rennin-angiotensin aldosterone system. Recent evidence suggests that stimulation of the renal dopaminergic system and possibly activation of AT2 receptors, as well as decreasing reactive oxygen species, may provide additional therapeutic approaches.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19077686      PMCID: PMC2847451          DOI: 10.1097/MNH.0b013e32831a9e0b

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  35 in total

1.  The angiotensin II AT2 receptor is an AT1 receptor antagonist.

Authors:  S AbdAlla; H Lother; A M Abdel-tawab; U Quitterer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

2.  Renal angiotensin II type-2 receptors are upregulated and mediate the candesartan-induced natriuresis/diuresis in obese Zucker rats.

Authors:  Amer C Hakam; Tahir Hussain
Journal:  Hypertension       Date:  2004-12-13       Impact factor: 10.190

3.  Rat strain effects of AT1 receptor activation on D1 dopamine receptors in immortalized renal proximal tubule cells.

Authors:  Chunyu Zeng; Zheng Wang; Ulrich Hopfer; Laureano D Asico; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2005-09-19       Impact factor: 10.190

4.  Dopamine decreases expression of type-1 angiotensin II receptors in renal proximal tubule.

Authors:  H F Cheng; B N Becker; R C Harris
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Influence of Na+ intake on dopamine-induced inhibition of renal cortical Na(+)-K(+)-ATPase.

Authors:  I Seri; B C Kone; S R Gullans; A Aperia; B M Brenner; B J Ballermann
Journal:  Am J Physiol       Date:  1990-01

6.  D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure.

Authors:  Zhiwei Yang; Laureano D Asico; Peiying Yu; Zheng Wang; John E Jones; Crisanto S Escano; Xiaoyan Wang; Mark T Quinn; David R Sibley; Guillermo G Romero; Robin A Felder; Pedro A Jose
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-01       Impact factor: 3.619

7.  G protein-coupled receptor kinase 4 gene variants in human essential hypertension.

Authors:  Robin A Felder; Hironobu Sanada; Jing Xu; Pei-Ying Yu; Zheng Wang; Hidetsuna Watanabe; Laureano D Asico; Wei Wang; Shaopeng Zheng; Ikuyo Yamaguchi; Scott M Williams; James Gainer; Nancy J Brown; Debra Hazen-Martin; Lee-Jun C Wong; Jean E Robillard; Robert M Carey; Gilbert M Eisner; Pedro A Jose
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

8.  Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells.

Authors:  Chunyu Zeng; Zhiwei Yang; Zheng Wang; John Jones; Xiaoyan Wang; Joanna Altea; Amy J Mangrum; Ulrich Hopfer; David R Sibley; Gilbert M Eisner; Robin A Felder; Pedro A Jose
Journal:  Hypertension       Date:  2005-02-07       Impact factor: 10.190

9.  Dopamine antagonizes the actions of angiotensin II in renal brush-border membrane.

Authors:  D Sheikh-Hamad; Y P Wang; O D Jo; N Yanagawa
Journal:  Am J Physiol       Date:  1993-04

10.  Production and role of extracellular guanosine cyclic 3', 5' monophosphate in sodium uptake in human proximal tubule cells.

Authors:  Shota Sasaki; Helmy M Siragy; John J Gildea; Robin A Felder; Robert M Carey
Journal:  Hypertension       Date:  2004-01-12       Impact factor: 10.190

View more
  29 in total

1.  Role of Gα(12)- and Gα(13)-protein subunit linkage of D(3) dopamine receptors in the natriuretic effect of D(3) dopamine receptor in kidney.

Authors:  Ye Zhang; Chunjiang Fu; Laureano D Asico; Van Anthony M Villar; Hongmei Ren; Duofen He; Zhen Wang; Jian Yang; Pedro A Jose; Chunyu Zeng
Journal:  Hypertens Res       Date:  2011-06-02       Impact factor: 3.872

2.  Dopamine receptor subtypes in the native human heart.

Authors:  Carlo Cavallotti; Massimo Mancone; Paolo Bruzzone; Maurizio Sabbatini; Fiorenzo Mignini
Journal:  Heart Vessels       Date:  2010-09       Impact factor: 2.037

3.  Oxidative stress alters renal D1 and AT1 receptor functions and increases blood pressure in old rats.

Authors:  Gaurav Chugh; Mustafa F Lokhandwala; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2010-10-13

Review 4.  Dopamine Receptors and Neurodegeneration.

Authors:  Claudia Rangel-Barajas; Israel Coronel; Benjamín Florán
Journal:  Aging Dis       Date:  2015-10-01       Impact factor: 6.745

5.  Bidirectional Neural Interaction Between Central Dopaminergic and Gut Lesions in Parkinson's Disease Models.

Authors:  Pablo Garrido-Gil; Ana I Rodriguez-Perez; Antonio Dominguez-Meijide; Maria J Guerra; Jose L Labandeira-Garcia
Journal:  Mol Neurobiol       Date:  2018-02-05       Impact factor: 5.590

6.  Mitochondrial ATP-sensitive potassium channels enhance angiotensin-induced oxidative damage and dopaminergic neuron degeneration. Relevance for aging-associated susceptibility to Parkinson's disease.

Authors:  Jannette Rodriguez-Pallares; Juan Andres Parga; Belen Joglar; Maria Jose Guerra; Jose Luis Labandeira-Garcia
Journal:  Age (Dordr)       Date:  2011-06-29

Review 7.  Where Is Dopamine and how do Immune Cells See it?: Dopamine-Mediated Immune Cell Function in Health and Disease.

Authors:  S M Matt; P J Gaskill
Journal:  J Neuroimmune Pharmacol       Date:  2019-05-11       Impact factor: 4.147

8.  Age-related hypertension and salt sensitivity are associated with unique cortico-medullary distribution of D1R, AT1R, and NADPH-oxidase in FBN rats.

Authors:  Indira Pokkunuri; Gaurav Chugh; Imran Rizvi; Mohammad Asghar
Journal:  Clin Exp Hypertens       Date:  2015-01-06       Impact factor: 1.749

9.  Brain angiotensin and dopaminergic degeneration: relevance to Parkinson's disease.

Authors:  Jose L Labandeira-Garcia; Jannette Rodriguez-Pallares; Ana I Rodríguez-Perez; Pablo Garrido-Gil; Begoña Villar-Cheda; Rita Valenzuela; Maria J Guerra
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 10.  Renal dopamine and angiotensin II receptor signaling in age-related hypertension.

Authors:  Gaurav Chugh; Indira Pokkunuri; Mohammad Asghar
Journal:  Am J Physiol Renal Physiol       Date:  2012-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.